文献速递肝病

前B细胞白血病转录因子1通过激活肝星状细胞中IL-7信号通路促进肝纤维化

Pre-B-cell leukemia transcription factor 1 contributes to liver fibrosis by enabling IL-7 signaling in HSC.
PubMed 文献 · Hepatology · 2025-03-13

本研究通过肝纤维化相关单细胞RNA测序数据筛选出前B细胞白血病转录因子1(PBX1)为肝星状细胞(HSC)活化时最显著上调的转录因子,并阐明Notch3在转录水平上调PBX1,PBX1通过激活IL-7受体(IL7R/CD127)等促纤维化分子促进HSC活化,阻断IL-7-IL7R信号可改善小鼠肝纤维化,提示靶向IL-7信号干预肝纤维化的概念验证。

要点

  • PBX1是HSC活化时最显著上调的转录因子,Notch3在转录水平上调其表达。
  • PBX1通过激活IL7R等促纤维化分子促进HSC活化,IL7R与TGF-β受体I/II相互作用触发促纤维化信号。
  • 中和抗体阻断IL-7-IL7R信号可明显改善小鼠肝纤维化。

核心结论

  • 本研究揭示了PBX1在HSC活化中此前未被认识的作用,并为靶向IL-7信号干预肝纤维化提供概念验证。

研究设计与样本

  • 研究通过挖掘肝纤维化相关单细胞RNA测序数据集筛选出PBX1,并结合体外实验、小鼠模型及肝硬化患者样本进行验证。

主要发现

  • PBX1敲低在体外减轻HSC向肌成纤维细胞转化,并在小鼠中减轻肝纤维化。
  • 重组IL-7暴露促进HSC活化,而IL7R敲低阻碍HSC活化。
  • IL7R与TGF-β受体I/II相互作用触发促纤维化信号级联。
  • 中和抗体阻断IL-7-IL7R信号明显改善小鼠肝纤维化。
  • 在肝硬化患者中观察到PBX1、IL7R与HSC活化呈正相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Liver fibrosis, when dysregulated, contributes to irreversible loss of hepatic structure and function, heralding end-stage liver diseases, including cirrhosis and hepatocellular carcinoma (HCC). Hepatic stellate cells (HSCs) represent the common progenitor to myofibroblasts that produce extracellular matrix proteins to mediate liver fibrosis. In the present study, we investigated the role of Pre-B-cell leukemia transcription factor 1 (PBX1) in this process. APPROACH AND RESULTS: PBX1 was screened out of mining through liver fibrosis-related single-cell RNA-seq data sets as the most prominently upregulated transcription factor during HSC activation. Ingenuity pathway analysis, coupled with reporter assay and chromatin immunoprecipitation assay, demonstrated that Notch3 mediated the elevation of PBX1 expression at the transcriptional level in HSCs. PBX1 knockdown attenuated HSC-myofibroblast transition in vitro and liver fibrosis in mice. Integrated transcriptomic analysis suggested that PBX1 contributed to HSC activation by activating a host of pro-fibrogenic molecules, including IL-7 receptor (IL7R/CD127). Consistently, exposure to recombinant IL-7 promoted HSC activation, whereas IL7R knockdown hampered HSC activation. Mechanistically, IL7R interacted with TGF-β receptors (I/II) to trigger a pro-fibrogenic signaling cascade. Importantly, blockade of the IL-7-IL7R signaling with neutralizing antibodies markedly ameliorated liver fibrosis in mice. Finally, a positive correlation between PBX1, IL7R, and HSC activation was identified in patients with cirrhosis. CONCLUSIONS: Our data uncover a previously unappreciated role for PBX1 in HSC activation and provide proof of concept for targeting IL-7 signaling in the intervention of liver fibrosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Zhao Q, Liu H, Yang Z, et al. Pre-B-cell leukemia transcription factor 1 contributes to liver fibrosis by enabling IL-7 signaling in HSC. Hepatology. 2025. PMID: 40080840. doi:10.1097/HEP.0000000000001302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。